Clinical Trial Update: A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ITI-1284 for psychosis associated with Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Psychosis

Drugs mentioned

• ITI-1284

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Psychosis Associated With Alzheimer's Disease | Phase 2 | Status: RECRUITING